Opened in 2021, Guangzhou Concord Cancer Center is a tertiary cancer hospital located in China–Singapore Guangzhou Knowledge City. The hospital provides multidisciplinary cancer care supported by surgical oncology, medical oncology, radiation oncology, pathology, diagnostic imaging, nuclear medicine, and rehabilitation services.Treatment plans are developed through multidisciplinary evaluation based on each patient’s diagnosis, tumor type and location, disease stage, previous treatment, and overall health. Depending on the individual case, treatment may involve surgery, systemic therapy, conventional or precision radiotherapy, proton therapy, or a combination of approaches.For patients who may benefit from highly precise radiation delivery, proton therapy is considered as one of the available treatment options following specialist assessment. The hospital’s Varian ProBeam system began clinical operation in late 2024, enabling highly conformal radiation delivery while helping reduce unnecessary radiation exposure to surrounding healthy tissues.
Facilities
The Proton Therapy Center is equipped with the Varian ProBeam system, supported by advanced image guidance and precision proton delivery technologies for accurate, individualized treatment.
The hospital is planned to provide 400 beds, supporting comprehensive inpatient and multidisciplinary cancer care.
The hospital’s first phase is currently in operation, providing dedicated facilities for cancer diagnosis, treatment, and patient care.
Key specialties
OncologyGynecologyGastroenterologyGeneral Surgery
Clinical strengths.
Intensity-Modulated Proton Therapy
Proton therapy uses the Bragg-peak effect to concentrate radiation within the tumor target while limiting the exit dose, potentially reducing exposure to healthy tissues and critical organs. The hospital combines pencil-beam scanning and intensity-modulated proton therapy with CBCT image guidance and six-dimensional positioning. This approach is particularly valuable for selected pediatric tumors and tumors located near critical structures such as the brainstem, spinal cord, or optic pathways.
Multidisciplinary Cancer Care
Multidisciplinary consultation brings together pathology, imaging, surgery, radiation oncology, medical oncology, and supportive care. Treatment is selected according to tumor type, stage, molecular characteristics, physical condition, and previous therapy, integrating surgery, proton or photon radiotherapy, chemotherapy, targeted therapy, and immunotherapy, with plans adjusted as the patient’s condition changes.
Bone and Soft-Tissue Tumor Care
For bone and soft-tissue tumors, the hospital combines surgical oncology, pathology, imaging, systemic therapy, and precision radiotherapy through multidisciplinary care. Proton therapy may be evaluated for selected spinal, sacral, or skull-base chordomas and chondrosarcomas located near critical neurological structures, helping improve target coverage while limiting radiation exposure to the spinal cord, brainstem, and other healthy tissues.
